2008
DOI: 10.1001/archotol.134.7.743
|View full text |Cite
|
Sign up to set email alerts
|

Biological Markers and Prognosis in Recurrent Oral Cancer After Salvage Surgery

Abstract: To analyze the prognostic effect of epidermal growth factor receptor (EGFR), matrix metalloproteinases 2 and 9, and vascular endothelial growth factor expression in patients with locally recurrent oral carcinoma after salvage surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
41
0

Year Published

2009
2009
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(42 citation statements)
references
References 19 publications
1
41
0
Order By: Relevance
“…We found a prognostic value in univariate analysis showing significantly higher OS in patients with a disease-free interval of more than 12 months from initial treatment than those with less than 12 months. Consistent with these data, Agra et al 19,21 demonstrated that patients with recurrent disease occurring less than 1 year from initial treatment had a significantly worse prognosis than those with recurrent disease after 1 year, and Schwartz et al 10 reported that oral cancer patients with recurrence within 6 months had a worse salvage rate than those with recurrence after more than 6 months.…”
Section: Discussionmentioning
confidence: 83%
“…We found a prognostic value in univariate analysis showing significantly higher OS in patients with a disease-free interval of more than 12 months from initial treatment than those with less than 12 months. Consistent with these data, Agra et al 19,21 demonstrated that patients with recurrent disease occurring less than 1 year from initial treatment had a significantly worse prognosis than those with recurrent disease after 1 year, and Schwartz et al 10 reported that oral cancer patients with recurrence within 6 months had a worse salvage rate than those with recurrence after more than 6 months.…”
Section: Discussionmentioning
confidence: 83%
“…EGFR activation can enhance the malignant potential of epithelial tissues 37 . In some studies, EGFR overexpression had been correlated with poor prognostic in OSCC patients 2,38,73,74 , but these results were not confirmed in other investigations 19,75 . A single study had identified a significant association between the combined expression of EGFR, p53, and cyclin D1 and an unfavourable overall survival (OS) in OSCC patients 72 .…”
Section: Cell Cycle Acceleration and Proliferation Moleculesmentioning
confidence: 80%
“…Give rationale for sample size; if the study was designed to detect a specified effect size, give the target power and effect size. According to AGRA et al 2 , the poor prognosis of OSCC patients associated with EGFR overexpression is related to radiotherapy resistance. No influence on OSCC survival was found in the studies examining PCNA expression.…”
Section: Discussionmentioning
confidence: 99%
“…Investigation of biomarkers' presence, quantity and expression pattern would help to correlate to the probability of malignant transformation of a cell or tissue. Evaluation of biomarkers would also help to identify patients who require more aggressive management (Agra et al, 2008). Immunohistochemical analysis of biomarkers could help to establish a direct association between the morphology and the biomarkers, which can aid in determining their functional relevance (Garcıa-Montesinos-Perea et al, 2005).…”
Section: Introductionmentioning
confidence: 99%